.

Sanchez, A. M., Orlandi, A., Franceschini, G., De Lauretis, F., Terribile, D. A., Franco, A., Masetti, R., OlympiAD trial: moving to a next level of treatment for patients with BRCA mutation and her2-negative metastatic breast cancer, <<ANNALS OF PALLIATIVE MEDICINE>>, 2020; 9 (2): 510-511. [doi:10.21037/apm.2020.01.14] [http://hdl.handle.net/10807/152609]

OlympiAD trial: moving to a next level of treatment for patients with BRCA mutation and her2-negative metastatic breast cancer

Orlandi, Armando;Franceschini, Gianluca;De Lauretis, Flavia;Terribile, Daniela Andreina;Franco, Antonio;Masetti, Riccardo
2020

Abstract

.
2020
Inglese
Sanchez, A. M., Orlandi, A., Franceschini, G., De Lauretis, F., Terribile, D. A., Franco, A., Masetti, R., OlympiAD trial: moving to a next level of treatment for patients with BRCA mutation and her2-negative metastatic breast cancer, <<ANNALS OF PALLIATIVE MEDICINE>>, 2020; 9 (2): 510-511. [doi:10.21037/apm.2020.01.14] [http://hdl.handle.net/10807/152609]
File in questo prodotto:
File Dimensione Formato  
OlympiAD trial moving to a next level of treatment for patients with BRCA mutation and her2-negative metastatic breast cancer.pdf

accesso aperto

Tipologia file ?: Versione Editoriale (PDF)
Licenza: Creative commons
Dimensione 117.28 kB
Formato Adobe PDF
117.28 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10807/152609
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 1
social impact